*Result*: SPP1 in notochord cells modulates intervertebral disc degeneration through CD44 recognition by macrophages based on single-cell transcriptome analysis.

Title:
SPP1 in notochord cells modulates intervertebral disc degeneration through CD44 recognition by macrophages based on single-cell transcriptome analysis.
Authors:
Li Q; Department of Orthopedics and Spine Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Laboratory of Spinal and Spinal Cord Injury Regeneration and Repair, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China., Jin P; Department of Orthopedics and Spine Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Laboratory of Spinal and Spinal Cord Injury Regeneration and Repair, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China., Zhao C; Department of Orthopedics and Spine Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Laboratory of Spinal and Spinal Cord Injury Regeneration and Repair, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China., Zhang R; Department of Orthopedics and Spine Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Laboratory of Spinal and Spinal Cord Injury Regeneration and Repair, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China., Shen C; Department of Orthopedics and Spine Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Laboratory of Spinal and Spinal Cord Injury Regeneration and Repair, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Source:
International journal of surgery (London, England) [Int J Surg] 2026 Jan 01; Vol. 112 (1), pp. 352-372. Date of Electronic Publication: 2025 Oct 07.
Publication Type:
Journal Article
Language:
English
Journal Info:
Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101228232 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-9159 (Electronic) Linking ISSN: 17439159 NLM ISO Abbreviation: Int J Surg Subsets: MEDLINE
Imprint Name(s):
Publication: 2023- : [Philadelphia] : Wolters Kluwer Health, Inc.
Original Publication: London : Surgical Associates Ltd., c2004-
References:
FASEB J. 2021 Nov;35(11):e21919. (PMID: 34591994)
Curr Stem Cell Res Ther. 2015;10(4):284. (PMID: 25982533)
Cell Biol Toxicol. 2025 Jan 18;41(1):33. (PMID: 39825191)
Transl Res. 2024 Oct;272:1-18. (PMID: 38823438)
Nat Biotechnol. 2018 Jun;36(5):411-420. (PMID: 29608179)
Comput Methods Programs Biomed. 2022 Sep;224:106982. (PMID: 35797747)
Brief Bioinform. 2019 Nov 27;20(6):2316-2326. (PMID: 30137247)
J Orthop Res. 2021 Sep;39(9):1933-1944. (PMID: 33049071)
Front Cell Dev Biol. 2022 Feb 28;9:833420. (PMID: 35295968)
Vet Pathol. 2022 Mar;59(2):284-298. (PMID: 35291907)
Transl Res. 2017 Mar;181:49-58. (PMID: 27986604)
Methods Mol Biol. 2017;1601:27-41. (PMID: 28470515)
Matrix Biol. 2020 Dec;94:110-133. (PMID: 33027692)
Ageing Res Rev. 2023 Jun;87:101902. (PMID: 36871778)
Libyan J Med. 2023 Dec;18(1):2212481. (PMID: 37192334)
Front Immunol. 2022 Aug 18;13:922173. (PMID: 36059551)
Front Cell Dev Biol. 2022 Feb 21;10:824771. (PMID: 35265617)
Nat Rev Rheumatol. 2022 Jan;18(1):47-60. (PMID: 34845360)
JOR Spine. 2021 Apr 08;4(3):e1146. (PMID: 34611583)
Curr Stem Cell Res Ther. 2023;18(2):163-173. (PMID: 35466881)
Cells. 2022 Feb 09;11(4):. (PMID: 35203253)
Eur J Radiol. 2022 Jul;152:110358. (PMID: 35584598)
Adv Sci (Weinh). 2022 May;9(13):e2104888. (PMID: 35195356)
JOR Spine. 2022 Dec 20;6(1):e1234. (PMID: 36994459)
World Neurosurg. 2022 Sep;165:e357-e364. (PMID: 35724886)
Biomater Res. 2024 Dec 23;28:0118. (PMID: 39717477)
Tissue Eng Part A. 2019 Jun;25(11-12):830-841. (PMID: 29739272)
Curr Stem Cell Res Ther. 2023;18(5):595-607. (PMID: 35762555)
Nat Protoc. 2023 Mar;18(3):732-754. (PMID: 36451054)
J Inflamm Res. 2024 Jun 14;17:3825-3838. (PMID: 38903877)
EFORT Open Rev. 2023 Mar 14;8(3):135-147. (PMID: 36916744)
Int J Mol Sci. 2022 Apr 03;23(7):. (PMID: 35409356)
Drug Des Devel Ther. 2023 Feb 20;17:535-550. (PMID: 36845666)
PLoS Biol. 2010 Jun 29;8(6):e1000412. (PMID: 20613859)
Cell Rep. 2024 Jun 25;43(6):114342. (PMID: 38865240)
Cell Prolif. 2024 Feb;57(2):e13541. (PMID: 37697480)
Genome Res. 2020 Feb;30(2):195-204. (PMID: 31992614)
BMC Musculoskelet Disord. 2024 Dec 19;25(1):1029. (PMID: 39702055)
J Orthop Translat. 2022 Apr 01;33:162-173. (PMID: 35415072)
iScience. 2023 Apr 19;26(5):106692. (PMID: 37216089)
Spine J. 2016 Sep;16(9):1079-89. (PMID: 27157501)
Adv Sci (Weinh). 2023 May;10(14):e2206296. (PMID: 36965031)
J Nanobiotechnology. 2023 Nov 28;21(1):453. (PMID: 38017517)
Mater Today Bio. 2022 Dec 17;18:100523. (PMID: 36590980)
World J Stem Cells. 2020 Apr 26;12(4):266-276. (PMID: 32399135)
Biomed Pharmacother. 2023 Sep;165:115224. (PMID: 37516017)
Front Surg. 2023 Mar 10;9:1089244. (PMID: 36969323)
Spine J. 2024 Feb;24(2):373-386. (PMID: 37797841)
Osteoarthritis Cartilage. 2015 Jul;23(7):1057-70. (PMID: 25827971)
Cells. 2021 Aug 29;10(9):. (PMID: 34571890)
Nat Rev Genet. 2019 May;20(5):257-272. (PMID: 30696980)
Theranostics. 2021 Jan 1;11(1):27-47. (PMID: 33391459)
JOR Spine. 2023 Jul 09;6(3):e1272. (PMID: 37780826)
Sci Rep. 2024 Nov 8;14(1):27245. (PMID: 39516278)
Mol Plant. 2020 Aug 3;13(8):1178-1193. (PMID: 32592820)
Semin Cell Dev Biol. 2022 Jul;127:3-9. (PMID: 34865989)
Mol Ther Nucleic Acids. 2022 Mar 28;28:387-396. (PMID: 35505959)
World J Stem Cells. 2021 Dec 26;13(12):1881-1904. (PMID: 35069988)
Sci Rep. 2021 Jan 12;11(1):772. (PMID: 33437038)
Brief Bioinform. 2020 Sep 25;21(5):1581-1595. (PMID: 31675098)
Cell Prolif. 2023 Oct;56(10):e13464. (PMID: 37025067)
Inflammation. 2019 Oct;42(5):1575-1584. (PMID: 31111299)
J Bone Joint Surg Am. 2006 Apr;88 Suppl 2:52-7. (PMID: 16595444)
Genome Biol. 2019 Dec 10;20(1):269. (PMID: 31823809)
Osteoarthritis Cartilage. 2021 Sep;29(9):1324-1334. (PMID: 34242803)
Genes Dis. 2016 Apr 23;3(3):171-177. (PMID: 30258887)
J Cell Commun Signal. 2011 Mar;5(1):39-43. (PMID: 21484587)
Connect Tissue Res. 2023 Sep;64(5):413-427. (PMID: 37161923)
Contributed Indexing:
Keywords: SPP1-CD44 pathway; intervertebral disc degeneration; mechanical stress; notochord cells; single-cell transcriptomics
Substance Nomenclature:
0 (Hyaluronan Receptors)
106441-73-0 (Osteopontin)
Entry Date(s):
Date Created: 20251009 Date Completed: 20260123 Latest Revision: 20260124
Update Code:
20260130
PubMed Central ID:
PMC12825790
DOI:
10.1097/JS9.0000000000003454
PMID:
41065569
Database:
MEDLINE

*Further Information*

*Background: Intervertebral disc degeneration (IVDD) is a major cause of spinal disorders, often leading to chronic pain and mobility issues. Mechanical stress is a key factor in IVDD progression, but the underlying mechanisms remain unclear. In this study, we improved a rat intervertebral disc pressure model to explore how mechanical stress affects IVDD, focusing on notochord cell populations and their interactions in the degenerative process.
Methods: We developed a custom pressure device for rats, validated using imaging techniques. Following pressure application, single-cell transcriptomics was employed to analyze dynamic changes in notochord cells in both surgical and sham groups. Gene expression profiles were analyzed for immune regulation, matrix metabolism, and intercellular signaling. We also studied the SPP1 signaling pathway and its interaction with CD44. Finally, we combined Mendelian randomization and human GEO sequencing data to support our results.
Results: Pressure application resulted in significant structural damage and abnormal changes in matrix components, worsening over time. Single-cell analysis revealed differences in notochord cell populations between surgical and sham groups, with increased immune regulation and matrix metabolism activity. The SPP1-CD44 signaling pathway was activated in degenerated discs, especially in CD44-expressing cells, underscoring its role in matrix remodeling and inflammation. MR and human GEO sequencing data also support these ideas.
Conclusion: This study provides insights into IVDD mechanisms, focusing on the role of the SPP1-CD44 pathway in disc degeneration. We suggest that targeting this pathway may offer potential therapeutic strategies for degenerative spinal diseases.
(Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.)*